Live feed09:00:00·66dPRReleasevia Quantisnow+2Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026ByQuantisnow·Wall Street's wire, on your screen.BNTX· BioNTech SECRSP· CRISPR Therapeutics AGIBRX· ImmunityBio Inc.NVCR· NovoCure LimitedONCY· Oncolytics Biotech Inc.Health Care
